Ladenburg Thalmann Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $73K | Sell |
754
-1,213
| -62% | -$117K | ﹤0.01% | 3253 |
|
2019
Q3 | $158K | Buy |
1,967
+1,130
| +135% | +$90.8K | ﹤0.01% | 2633 |
|
2019
Q2 | $61K | Buy |
837
+434
| +108% | +$31.6K | ﹤0.01% | 3319 |
|
2019
Q1 | $37K | Hold |
403
| – | – | ﹤0.01% | 3604 |
|
2018
Q4 | $29K | Buy |
403
+103
| +34% | +$7.41K | ﹤0.01% | 3639 |
|
2018
Q3 | $27K | Buy |
+300
| New | +$27K | ﹤0.01% | 3703 |
|
2018
Q1 | – | Sell |
-225
| Closed | -$29K | – | 5095 |
|
2017
Q4 | $29K | Sell |
225
-326
| -59% | -$42K | ﹤0.01% | 3561 |
|
2017
Q3 | $65K | Sell |
551
-35
| -6% | -$4.13K | ﹤0.01% | 2908 |
|
2017
Q2 | $47K | Buy |
586
+225
| +62% | +$18K | ﹤0.01% | 3066 |
|
2017
Q1 | $18K | Sell |
361
-515
| -59% | -$25.7K | ﹤0.01% | 3613 |
|
2016
Q4 | $33K | Sell |
876
-219
| -20% | -$8.25K | ﹤0.01% | 3138 |
|
2016
Q3 | $75K | Sell |
1,095
-2,399
| -69% | -$164K | ﹤0.01% | 2456 |
|
2016
Q2 | $194K | Buy |
3,494
+2,853
| +445% | +$158K | ﹤0.01% | 1702 |
|
2016
Q1 | $41K | Buy |
641
+215
| +50% | +$13.8K | ﹤0.01% | 2733 |
|
2015
Q4 | $40K | Buy |
426
+100
| +31% | +$9.39K | ﹤0.01% | 2726 |
|
2015
Q3 | $26K | Sell |
326
-27
| -8% | -$2.15K | ﹤0.01% | 2922 |
|
2015
Q2 | $42K | Sell |
353
-53
| -13% | -$6.31K | ﹤0.01% | 2702 |
|
2015
Q1 | $42K | Sell |
406
-133
| -25% | -$13.8K | ﹤0.01% | 2680 |
|
2014
Q4 | $52K | Buy |
539
+239
| +80% | +$23.1K | ﹤0.01% | 2335 |
|
2014
Q3 | $23K | Hold |
300
| – | – | ﹤0.01% | 2530 |
|
2014
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 2694 |
|
2014
Q1 | $20K | Sell |
300
-100
| -25% | -$6.67K | ﹤0.01% | 2563 |
|
2013
Q4 | $26K | Hold |
400
| – | – | ﹤0.01% | 2358 |
|
2013
Q3 | $26K | Sell |
400
-900
| -69% | -$58.5K | ﹤0.01% | 2262 |
|
2013
Q2 | $40K | Buy |
+1,300
| New | +$40K | ﹤0.01% | 1870 |
|